305 related articles for article (PubMed ID: 30328786)
1. Angioedema: a rare and sometimes delayed side effect of angiotensin-converting enzyme inhibitors.
Davin L; Marechal P; Lancellotti P; Martinez C; Pierard L; Radermecker R
Acta Cardiol; 2019 Aug; 74(4):277-281. PubMed ID: 30328786
[TBL] [Abstract][Full Text] [Related]
2. Serum metabolism of bradykinin and des-Arg9-bradykinin in patients with angiotensin-converting enzyme inhibitor-associated angioedema.
Blais C; Rouleau JL; Brown NJ; Lepage Y; Spence D; Munoz C; Friborg J; Geadah D; Gervais N; Adam A
Immunopharmacology; 1999 Sep; 43(2-3):293-302. PubMed ID: 10596866
[TBL] [Abstract][Full Text] [Related]
3. ACE inhibitor-mediated angioedema.
Montinaro V; Cicardi M
Int Immunopharmacol; 2020 Jan; 78():106081. PubMed ID: 31835086
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of bradykinin effect by angiotensin-converting enzyme inhibition does not correlate with angiotensin-converting enzyme activity in the rat mesenteric arteries.
Sivieri DO; Bispo-da-Silva LB; Oliveira EB; Resende AC; Salgado MC
Hypertension; 2007 Jul; 50(1):110-5. PubMed ID: 17470724
[TBL] [Abstract][Full Text] [Related]
5. [Drug induced angioedema (ACE-inhibitors and other)].
Fain O; Mekinian A; Gobert D; Khau CA; Javaud N
Presse Med; 2015 Jan; 44(1):43-7. PubMed ID: 25511647
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme inhibitor-associated angioedema is characterized by a slower degradation of des-arginine(9)-bradykinin.
Molinaro G; Cugno M; Perez M; Lepage Y; Gervais N; Agostoni A; Adam A
J Pharmacol Exp Ther; 2002 Oct; 303(1):232-7. PubMed ID: 12235256
[TBL] [Abstract][Full Text] [Related]
7. Contribution of angiotensin-converting enzyme to the cardiac metabolism of bradykinin: an interspecies study.
Blais C; Drapeau G; Raymond P; Lamontagne D; Gervais N; Venneman I; Adam A
Am J Physiol; 1997 Nov; 273(5):H2263-71. PubMed ID: 9374762
[TBL] [Abstract][Full Text] [Related]
8. Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor associated angioedema.
Byrd JB; Touzin K; Sile S; Gainer JV; Yu C; Nadeau J; Adam A; Brown NJ
Hypertension; 2008 Jan; 51(1):141-7. PubMed ID: 18025295
[TBL] [Abstract][Full Text] [Related]
9. Is dipeptidylpeptidase IV the missing link in angiotensin-converting enzyme inhibitor--induced angioedema?
Grouzmann E; Buclin T
Hypertension; 2008 Jan; 51(1):45-7. PubMed ID: 18025291
[No Abstract] [Full Text] [Related]
10. Angioedema after local trauma in a patient on angiotensin-converting enzyme inhibitor therapy.
Simmons BB; Folsom MA; Bryden LA; Studdiford JS
J Am Board Fam Med; 2008; 21(6):577-9. PubMed ID: 18988727
[TBL] [Abstract][Full Text] [Related]
11. [Angiotensin-converting enzyme inhibitor induced angioedema : new therapy options].
Bas M; Kojda G; Stelter K
Anaesthesist; 2011 Dec; 60(12):1141-5. PubMed ID: 20922352
[TBL] [Abstract][Full Text] [Related]
12. [Management of angiotensin-converting enzyme inhibitor-related angioedema: recommendations from the French National Center for Angioedema].
Nosbaum A; Bouillet L; Floccard B; Javaud N; Launay D; Boccon-Gibod I; Fain O; ;
Rev Med Interne; 2013 Apr; 34(4):209-13. PubMed ID: 23380506
[TBL] [Abstract][Full Text] [Related]
13. ACE Inhibitor-Induced Angioedema: a Review.
Kostis WJ; Shetty M; Chowdhury YS; Kostis JB
Curr Hypertens Rep; 2018 Jun; 20(7):55. PubMed ID: 29884969
[TBL] [Abstract][Full Text] [Related]
14. In vitro comparison of bradykinin degradation by aliskiren, a renin inhibitor, and an inhibitor of angiotensin-converting enzyme.
Joseph K; Tholanikunnel TE; Kaplan AP
J Renin Angiotensin Aldosterone Syst; 2015 Jun; 16(2):321-7. PubMed ID: 23764715
[TBL] [Abstract][Full Text] [Related]
15. [Drug-induced angioedema : Focus on bradykinin].
Sachs B; Meier T; Nöthen MM; Stieber C; Stingl J
Hautarzt; 2018 Apr; 69(4):298-305. PubMed ID: 29392343
[TBL] [Abstract][Full Text] [Related]
16. Iatrogenic angioedema associated with ACEi, sitagliptin, and deficiency of 3 enzymes catabolizing bradykinin.
Beaudouin E; Defendi F; Picaud J; Drouet C; Ponard D; Moneret-Vautrin DA
Eur Ann Allergy Clin Immunol; 2014 May; 46(3):119-22. PubMed ID: 24853572
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Life-Threatening ACE-Inhibitor-Induced Angioedema.
Hirschy R; Shah T; Davis T; Rech MA
Adv Emerg Nurs J; 2018; 40(4):267-277. PubMed ID: 30365440
[TBL] [Abstract][Full Text] [Related]
18. Angioedema due to angiotensin-converting enzyme inhibitors.
Agostoni A; Cicardi M; Cugno M; Zingale LC; Gioffré D; Nussberger J
Immunopharmacology; 1999 Oct; 44(1-2):21-5. PubMed ID: 10604520
[TBL] [Abstract][Full Text] [Related]
19. Dipeptidyl Peptidase-4 Inhibitor Induced Angioedema - An Overlooked Adverse Drug Reaction?
Scott SI; Andersen MF; Aagaard L; Buchwald CV; Rasmussen ER
Curr Diabetes Rev; 2018; 14(4):327-333. PubMed ID: 28201967
[TBL] [Abstract][Full Text] [Related]
20. [Angioedema during ACE and DPP-4 inhibition].
Waeber B; Buclin T; Grouzmann E
Rev Med Suisse; 2010 Jan; 6(231):28-31. PubMed ID: 20196430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
